CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine

被引：17
|
作者：
Capi, Matilde [1 ]
De Angelis, Valerio [2 ]
De Bernardini, Donatella [1 ]
De Luca, Ottavia [3 ]
Cipolla, Fabiola [2 ]
Lionetto, Luana [1 ]
Simmaco, Maurizio [1 ,3 ,4 ]
Martelletti, Paolo [2 ]
机构：
[1] St Andrea Univ Hosp, Mass Spectrometry Unit, Lab Clin Biochem, I-00185 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, I-00185 Rome, Italy
[3] St Andrea Univ Hosp, Adv Mol Diagnost Unit, Lab Clin Biochem, I-00185 Rome, Italy
[4] Sapienza Univ, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 07期
关键词：
migraine; CGRP; therapy; gepants; ditans; antagonism; CGRP receptor; GENE-RELATED PEPTIDE; MONOCLONAL-ANTIBODIES; SAFETY PROFILE; LASMIDITAN;
D O I：
10.3390/jcm10071429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Discovering that calcitonin-related peptide (CGRP) plays a key role in the complex pathophysiology of migraine has allowed us to make great strides in the development of new approaches for acute and preventive treatment. This evidence has led to the development of small molecules antagonist molecules of the CGRP receptor ("gepants") and of a new class of medications called "Ditans". This review presents the data from clinical trials reporting the efficacy, safety, and tolerability of the new drugs used in the treatment of migraines. Evidences show that therapeutic approaches targeted to CGRP have the potential to transform the clinical management of migraine, even though its appropriate place has yet to be determined with accuracy.
引用
收藏
页数：17
相关论文
共 50 条
  • [21] The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
    Tfelt-Hansen, Peer C.
    Olesen, Jes
    JOURNAL OF HEADACHE AND PAIN, 2012, 13 (04) : 271 - 275
  • [22] Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
    de Vries, Tessa
    Villalon, Carlos M.
    MaassenVanDenBrink, Antoinette
    PHARMACOLOGY & THERAPEUTICS, 2020, 211
  • [23] Lasmiditan mechanism of action – review of a selective 5-HT1F agonist
    David B. Clemow
    Kirk W. Johnson
    Helen M. Hochstetler
    Michael H. Ossipov
    Ann M. Hake
    Andrew M. Blumenfeld
    The Journal of Headache and Pain, 2020, 21
  • [24] CGRP Receptor Antagonists: Toward a Novel Migraine Therapy
    Salvatore, C. A.
    Kane, S. A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (10) : 1671 - 1680
  • [25] New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
    Hoffmann, Jan
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (01) : 50 - 59
  • [26] Chromosomal localization of the 5-HT1F receptor gene:: No evidence for involvement in response to sumatriptan in migraine patients
    VanDenBrink, AM
    Vergouwe, MN
    Ophoff, RA
    Naylor, SL
    Dauwerse, HG
    Saxena, PR
    Ferrari, MD
    Frants, RR
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 77 (05): : 415 - 420
  • [27] Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review
    Ribeiro dos Santos, Jessica Barreto
    Ribeiro da Silva, Michael Ruberson
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 922
  • [28] Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan
    Rubio-Beltran, Eloisa
    Labastida-Ramirez, Alejandro
    Haanes, Kristian A.
    van den Bogaerdt, Antoon
    Bogers, Ad J. J. C.
    Zanelli, Eric
    Meeus, Laurent
    Danser, A. H. Jan
    Gralinski, Michael R.
    Senese, Peter B.
    Johnson, Kirk W.
    Kovalchin, Joseph
    Villalon, Carlos M.
    MaassenVanDenBrink, Antoinette
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (24) : 4681 - 4695
  • [29] The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
    Villalon, Carlos M.
    Olesen, Jes
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (03) : 309 - 323
  • [30] Innovative treatment of acute migraine pain with CGRP receptor antagonists
    Herbert, MK
    Holzer, P
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2004, 39 (11): : 657 - 661
12345